Influence of cetirizine and levocetirizine on two cytokines secretion in human airway epithelial cells

Allergy and Asthma Proceedings

Volumn 29, Issue 5, 2008, Pages 480-485

  Shih, Mei Yin ^a   Hsu, Jeng Yuan ^b,c   Weng, Yueh Shan ^a   Fu, Lin Shien ^a,b  

^a Division of Immunology and Nephrology

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

A549 cells; Cetirizine; Cytokines; Granulocyte macrophage colony stimulating factor; Interleukin 1beta; Interleukin 8; Levocetirizine; Secondary generation antihistamines

Indexed keywords

CETIRIZINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEVOCETIRIZINE;

ARTICLE; CELL SURVIVAL; DRUG EFFECT; HUMAN; IMMUNOLOGY; METABOLISM; RESPIRATORY TRACT MUCOSA; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; CETIRIZINE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; RESPIRATORY MUCOSA;

EID: 54049097942     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3156     Document Type: Article

References (31)

1. Broide DH. The pathphysiology of allergic rhinitis. Allergy Asthma Proc 28:398-403, 2007.
2. Fumagalli F, Baiardini I, Pasquali M, et al. Antihistamines: do they work? Further well-controlled trials involving larger samples are needed. Allergy 59(suppl 78):74-77, 2004.
3. Nettis E, Colanardi MC, Ferrannini A, et al. Antihistamines as important tools for regulating inflammation. Curr Med Chem Anti-Inflamm Anti-Allergy Agents 4:81-89, 2005.
4. Tillement JP, Testa B, and Brée F. Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine, two histamine H1-receptor antagonists. Biochem Pharmacol 66:1123-1126, 2003.
5. Baltes E, Coupez R, Giezek H, et al. Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers. Fundam Clin Pharmacol 15:269-277, 2001.
6. Leurs R, Church MK, and Taglialatela M. H1-antihistamines: Inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 32:489-498, 2002.
7. Walsh GM, Annunziato L, Frossard N, et al. New insights into the second generation antihistamines. Drugs 61:207-236, 2001.
8. Lee SC, Hsu JY, Fu LS, et al. Comparison of the activities of granulocyte-macrophage colony-stimulating factor and interleukin-8 secretion between two lung epithelial cell lines. J Microbiol Immunol Infect 38:327-331, 2005.
9. Polito AJ, and Proud D. Epithelial cells as regulators of airway inflammation. J Allergy Clin Immunol 102:714-718, 1998.
10. Borish LC, and Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol 111:S460-S475, 2003.
11. Cheng KC, Hsu JY, Fu LS, et al. Influence of cetirizine and loratadine on granulocyte-macrophage colony-stimulating factor and interleukin-8 release in A549 human airway epithelial cells stimulated with interleukin-1beta. J Microbiol Immunol Infect 39:206-211, 2006.
12. Wickremasinghe MI, Thomas LH, and Friedland JS. Pulmonary epithelial cells are a source of IL-8 in the response to mycobacterium tuberculosis: Essential role of IL-1 from infected monocytes in a NF-kB-dependent network. J Immunol 163:3936-3947, 1999.
13. Lieber M, Smith B, Szakal A, et al. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17:62-70, 1976.
14. Mosmann T. Rapid colorimetric assay for cellular growth and suvival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983.
15. Passalacqua G, and Canonica GW. A Review of the evidence from comparative Studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis. Clin Ther 27:979-992, 2005.
16. Ciprandi G, Cirillo I, Vizzaccaro A, et al. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: A pilot study. Clin Exp Allergy 34:958-964, 2004.
17. Day J, Briscoe M, and Ratz J. Efficacy of levocetirizine compared with montelukast in subjects with ragweed-induced seasonal allergic rhinitis in the Environmental Exposure Unit. Allergy Asthma Proc 29:304-312, 2008.
18. Thomson L, Blaylock MG, Sexton DW, et al. Cetirizine and levocetirizine inhibit eotaxin-induced eosiriophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy 32:1187-1192, 2002.
19. Fasce L, Ciprandi G, Pronzato C, et al. Cetirizine reduces ICAM-1 on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma. Int Arch Allergy Immunol 109:272-276, 1996.
20. Hasala H, Janka-Junttila M, Moilanen E, and Kankaanranta H. Levocetirizine and cytokine production and apoptosis of human eosinophils. Allergy Asthma Proc 28:582-591, 2007.
21. Church MK. Non-H1 receptor effects of antihistamines. Clin Exp Allergy 29(suppl 3):39-48, 1999.
22. Arnold R, Rihoux J, and König W. Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549). Clin Exp Allergy 29:1681-1691, 1999.
23. Devalia JL, De Vos C, Hanotte F, et al. A randomised, doubleblind, crossover comparison among cetirizine, levocetirizine, UCB 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Allergy 56:50-57, 2001.
24. Wang DY, Hanotte F, De Vos C, et al. Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine induced nasal response in healthy adult volunteers. Allergy 56:339-343, 2001.
25. Dubuske LM. Levocetirizine: The latest treatment option for allergic rhinitis and chronic idiopathic urticaria. Allergy Asthma Proc 28:724-734, 2007.
26. Gillard M, Van Der Perren C, Moguilevsky N, et al. Binding characteristics of cetirizine and levocetirizine to human H1 histamine receptors: Contribution of Lys191 and Thr194. Mol Pharmacol 61:391-399, 2002.
27. Rédier H, Chanez P, De Vos C, et al. Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 90:215-224, 1992.
28. Albanesi C, Pastore S, Fanales-Belasio E, et al. Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes. Clin Exp Allergy 28:101-109, 1998.
29. Jinquan T, Reimert CM, Deleuran B, et al. Cetirizine inhibits the in vitro and ex vivo chemotactic responses of T lymphocytes and monocytes. J Allergy Clin Immunol 95:979-986, 1995.
30. Fasce L, Ciprandi G, Pronzato C, et al. Cetirizine reduces ICAM-1 on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite allergic asthma. Int Arch Allergy Immunol 109:272-276, 1996.
31. Barnes PJ, and Karin M. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997.